key: cord-0745090-tagjk3u7
authors: Rapozzi, Valentina; Juarranz, Angeles; Habib, Ahsan; Ihan, Alojz; Strgar, Rebeka
title: Is haem the real target of COVID-19?
date: 2021-06-11
journal: Photodiagnosis Photodyn Ther
DOI: 10.1016/j.pdpdt.2021.102381
sha: 80101334117e3c96d09ea21c79004681fc53cba2
doc_id: 745090
cord_uid: tagjk3u7

Although a vaccination campaign has been launched in many countries, the COVID-19 pandemic is still not under control. The main concern is the emergence of new variants of SARS-CoV-2; therefore, it is important to find new approaches to prevent or reduce the virulence and pathogenicity of the virus. Currently, the mechanism of action of SARS-CoV-2 is not fully understood. Considering the clinical effects that occur during the disease, attacking the human respiratory and hematopoietic systems, and the changes in biochemical parameters (including decreases in haemoglobin [Hb] levels and increases in serum ferritin), it is clear that iron metabolism is involved. SARS-CoV-2 induces haemolysis and interacts with Hb molecules via ACE2, CD147, CD26, and other receptors located on erythrocytes and/or blood cell precursors that produce dysfunctional Hb. A molecular docking study has reported a potential link between the virus and the beta chain of haemoglobin and attack on haem. Considering that haem is involved in miRNA processing by binding to the DCGR8-DROSHA complex, we hypothesised that the virus may check this mechanism and thwart the antiviral response.

To date, the COVID-19 pandemic has infected 165 million people worldwide, with 3,43 million deaths. Although a vaccination campaign has been launched, the situation is still not under control.

Medicines Agency (EMA) based on different mechanisms of action. Considering that these vaccines is the only way to eradicate the virus, the induced immunity does not seem to last. Moreover, the emergence of new variants, such as English, Brazilian, and Indian, which are much more contagious and aggressive, must be considered.

Therefore, it is important to find other strategies to prevent or reduce the virulence and pathogenicity of SARS-CoV-2.

Currently, the mechanism of action of SARS-CoV-2 remains unclear. In the early stages of the pandemic, clinical studies have shown systemic infection of patients, mainly attacking the respiratory and hematopoietic systems and homeostasis [1] . The biochemical parameters of the patients showed a decrease in haemoglobin (Hb) level [2] and an increase in serum ferritin, erythrocyte sedimentation rate, C-reactive protein, and lactate dehydrogenase [3, 4] . During the progression from mild to severe disease, an increase in bilirubin levels [5] , and in some cases, porphyria [6] were observed. These data support a link between SARS-CoV-2 and iron metabolism, similar with other RNA viruses, such as hepatitis C and B, Ebola, human immunodeficiency virus (HIV), dengue, and Zika [7, [8] [9] [10] [11] [12] .

Viral interactions with receptors located on erythrocytes and blood cell precursors and the haemoglobin molecule via ACE2, CD147, and CD26 have been highlighted [13] [14] [15] [16] [17] . Furthermore, a molecular docking study found that the viral ORF8 protein and surface glycoprotein bind to porphyrin and target haem on the 1-beta chain of Hb [18, 19] . SARS-CoV-2 induces haemolysis [20, 21] , forms a complex with the released haem [22] and generates a quote of dysfunctional Hb with reduced oxygen and CO2 transport [23] . Recent studies confirmed the increase in the production of haem and free haemoglobin [24] and demonstrated the link between SARS-CoV-2 and haem through a computational-experimental approach [25, 26] .

In this study, several lines of evidence suggest a potential link between virus and Hb: i) women who have lower Hb levels than men are less susceptible to infection COVID; ii) new-borns of infected mothers do not get sick; the beta chain of Hb appears a few weeks after birth; and iii) at the beginning of the pandemic, there was a very low percentage of clinical cases in many Mediterranean regions, such as Tunisia, Libya, Sardinia, and Sicily. This is possibly due to many patients with betathalassemia in these areas, a blood disease caused by abnormalities in the beta-chains of Hb [27] [28] [29] .

During the quarantine period in March 2020, a case report of Slovenian skiers with COVID brought our interest in studying this disease. They found benefit from irradiation benefit from of the thoracic region with red to near-infrared radiation (R/NIR) combined with 660 and 920 nm, at a total fluence of 10 J/cm 2 (i.e. two 5 J/cm 2 sessions per day) (data not published). The efficacy of this treatment was confirmed a few months later by a Brazilian study in humans [30] , based on an earlier study reporting the effect of light irradiation in mice with pneumonia [31] .

It is known that light irradiation can induce the production of reactive oxygen species (ROS) with an increase in haem oxygenases 1 (HO-1) [32, 33] , leading to the destruction of haem. This may be the reason why individuals with high HO-1 levels, such as smokers, have a lower risk of infection [34] .

It has been reported that the administration of hemin and metalloporphyrin, which upregulate HO-1 gene expression, inhibits the replication of viruses involved in iron metabolism, such as SARS-CoV-2 [35] , and leads to a decrease in neutrophil infiltration and pneumonia with an increase in the interferon response [36] .

All this evidence supports a strong relationship between COVID-19 and haem [19, 37] , although without any possible explanation.

Therefore, the important question is: why would the virus target haem? What would be beneficial to this?

Haem is the functional group of various proteins, including cytochromes, Hb, and myoglobin, and is crucial for many different biological processes [38] . Haem also enters the cells freely and modifies proteins, DNA, and lipids [39] [40] . Moreover, it can be transported out of the cell by the breast cancer resistance protein (BCRP) [41] . Haem also acts as a danger element in the signal damage-associated molecular pattern (DAMP) [37, [42] [43] [44] [45] and activates Toll-like receptor 4 signalling (TRL-4) [46] , which plays a crucial role in the innate immune system [47] .

In addition, haem has been reported to be involved in miRNA processing [48] . The RNA-binding protein DiGeorge critical region-8 (DGCR8), essential for the first processing step, is a haem-binding protein [49] . The association (DGCR8-haem) promotes the expression of DGCR8 and the formation of the microprocessor, a complex containing RNase Drosha and DGCR8 for processing pri-miRNAs [50, 51] . Thus, pri-miRNA processing is enhanced by haem both in vitro and in vivo, and variations in haem status can modulate DGCR8 activity. Therefore, haem can serve as a signalling molecule that regulates various functions, such as transcription [52, 53] , cell signalling [54] , and ion flux [55] . In addition, it is important to highlight that RNA interference (RNAi) functions in antiviral immunity [56] [57] [58] [59] [60] .

This could explain why the virus attacks haem. Considering that the virus must live and replicate by exploiting the host, it is possible that miRNA processing must be maintained under strict control [61, 62] to ensure its own gene expression and prevent host defence mechanisms that could destroy it [63] [Scheme]. Therefore, it is important to consider the crucial role of the coronavirus N protein [64, 65] . During the viral life cycle, the N protein encapsulates viral genomic RNAs to protect and introduce them into the host cell, suggesting that N is essential for viral RNA replication, particularly at the initiation step [66] . Moreover, N protein has been identified as a viral suppressor of RNA silencing (VSR) [65, 67] , which inhibits the production of viral siRNAs (vsiRNA) and the antiviral RNAi response during viral infection [68, 69] . RNA-binding of SARS-CoV N is critical for its antagonism to interferon induction [70] , as seen in ORF6 and ORF8 [71, 72] .

Furthermore, nonstructural protein 1 (nsp1) has been reported to bind to the 40S ribosomal subunit, resulting in the silencing of mRNA translation and blockage of retinoic acid-inducible gene I (RIG-I) and interferon-stimulated genes (ISGs), which are the key mediators of the innate immune responses against viral infection [73] . All data suggest that SARS-CoV-2 can antagonise RNAi in the initiation (i.e. siRNA biogenesis) and effector (i.e. RISC assembly and target cleavage) steps [66] .

Our hypothesis revealed a new vision for the mechanism of action of SARS-CoV-2 that can effectively act through haem functions. This study aims to encourage molecular biologists and virologists to identify new potential targets to improve therapeutic strategies against SARS-CoV-2.

It has been reported that photobiomodulation can reduce the virulence of the virus by reducing ARDS and accelerating the regeneration of damaged tissue [74] [75] [76] . The efficacy of photobiomodulation may be because the virus is trapped in porphyrins. Exogenous administration of 5-aminolaevulinic acid has been reported to inhibit SARS-CoV-2 infection in vitro [77] .

Our study will focus on the link between SARS-CoV-2, haem, and exogenous porphyrins capable of binding viral RNA, using the classical plaque reduction neutralisation test (PRNT). This study mainly aims to understand whether PDT could be a good therapeutic strategy [78] [79] [80] [81] .

Hematological findings and complications of COVID-19

Hemoglobin value may be decreased in patients with severe coronavirus disease 2019

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Bilirubin levels in patients with mild and severe Covid-19: a pooled analysis

COVID-19: acquired acute porphyria hypothesis. Last accessed: 19 th

Viral infection and iron metabolism

SARS-CoV-2 invades host cells via a novel route: CD147-spike protein

Prevalence and gene characteristics of antibodies with cofactor-induced HIV-1 specificity

Neutralization of Japanese Encephalitis Virus by heme-induced broadly reactive human monoclonal antibody

Inactivation of Dengue and Yellow Fever viruses by heme, cobalt-protoporphyrin IX and tin-protoporphyrin IX

Chikungunya and other arboviruses by targeting the viral envelope

Distribution of ACE2, CD147, cyclophilins, CD26 and other SARSCoV-2 associated molecules in human tissues and immune cells in health and disease

COVID-19: attacks the 1-Beta Chain of Hemoglobin and captures the porphyrin to inhibit human heme metabolism

RRM prediction of erythrocyte band 3 protein as alternative receptor for SARS-CoV-2 virus

Infection of red blood cells by SARS-CoV-2: new evidence

Evidence of Structural Protein Damage and Membrane Lipid Remodeling in Red Blood Cells from COVID-19 Patients

COVID-19 Disease: ORF8 and surface glycoprotein inhibit heme metabolism by binding to porphyrin, ChemRxix 2020

COVID-19:hemoglobin, iron, and hypoxia beyond inflammation. A narrative review

Circulating inflammatory cytokine levels in hemolytic uremic syndrome

Clinical applications of hemolytic markers in the differential diagnosis and management of hemolytic anemia

Reactive species generated by heme impair alveolar epithelial sodium channel function in acute respiratory distress syndrome

Desaturation and heme evaluation during COVID-19 infection: A potential prognostic factor of heme oxygenase-1

Linking COVID-19 and heme-driven pathophysiologies: a combined computational-experimental approach

HeMoQuest: A webserver for qualitative prediction of transient heme binding to protein motifs

COVID-19: beta-thalassemia subjects immunized?

Beta-thalassemia may protect against COVID 19

SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience

Photobiomodulation: Shining Light on COVID-19, Photobiomodul

Pneumonia treatment by photodynamic therapy with extracorporeal illumination-an experimental model

Heme Oxygenases: Cellular multifunctional and protective molecules against UV-induced oxidative stress

Photodynamic therapy of cancer: an update

COVID-19 and heme oxygenase: novel insight into the disease and potential therapies

Targeting the heme-heme oxygenases system to prevent severe complications following COVID-19 infections

Modulation of antiviral immunity by hemeoxygenase-1

Is hemoglobin the missing link in the pathogenesis of COVID-19?

Different faces of the heme-heme oxygenase system in inflammation

There is blood in the water: hemolysis, hemoglobin, and heme in acute lung injury

Hemin causes mitochondrial dysfunction in endothelial cells through promoting lipid peroxidation: the protective role of autophagy

Rapid mtDNA deletion by oxidants in rat liver mitochondria after hemin exposure, Free Radic

Heme Oxygenase-1 and breast cancer resistance protein protect against heme-induced toxicity

The hemeheme oxygenase system: a molecular switch in wound healing

Red alert: Labile heme is an alarmin

Red cell DAMPs and inflammation

Heme as a danger molecule in pathogen recognition, Free Radic

Characterization of heme as activator of Toll-like receptor 4

Toll-like receptor signaling pathways

Processing of microRNA primary transcripts requires heme in mammalian cells

Heme is involved in microRNA processing

Heme enables proper positioning of Drosha and DGCR8 on primary microRNAs

Microprocessor depends on hemin to recognize the apical loop of primary microRNA

Identification of heme as the ligand for the orphan nuclear receptors REV-ERB alpha and REV-ERB beta

Heme mediates derepression of Maf recognition element through direct binding to transcriprion repressor Bach 1

Structure and regulation of soluble guanylate cyclase

Heme can bind to and inhibit mammalian calcium-dependent Slo1 BK channels

RNA-based antiviral immunity

Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems

RNA interference functions as an antiviral immunity mechanism in mammalians

Antiviral RNA interference in mammalian cells

Molecular biology. RNAi, antiviral after all

MicroRNAs and viral infection

Induction and suppression of RNA silencing: insights from viral infections

On the importance of host microRNAs during viral infection

The nucleocapsid protein of coronaviruses acts as viral suppressor of RNA silencing in mammalian cells

The molecular virology of coronaviruses

SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells

Viral RNA silencing suppressors (RSS): novel strategy of viruses to ablate the host RNA interference (RNAi) defense system

Flavivirus induces and antagonizes antiviral RNA interference in both mammals and mosquitoes

Antiviral RNA interference in mammalians

SARS-CoV nucleocapsid protein antagonizes IFN-ß response by targeting initial step of IFN-ß inC-terminalduction pathway, and its C-terminal region is critical for the antagonism

The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway

Isolation of SARC-CoV-2 strains carrying a nucleotide mutation, leading to a stop codon in the ORF6 protein

Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2

Photobiomodulation therapy as a high potential treatment modality for COVID-19

Probable positive effects of the photobiomodulation as an adjunctive treatment in COVID-19: A systematic review

Evaluation of adjunctive photobiomodulation (PBMT) for COVID-19 pneumonia via clinical status and pulmonary severity indices in a preliminary trial

5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro

Antimicrobial photodynamic therapy with hypocrellin B against SARS-CoV-2 infection

Robust antimicrobial photodynamic therapy with curcumin-poly (lactic-coglycolitic acid) nanoparticles against COVID-19: A preliminary in vitro study in Vero cell line as a model

Photodynamic therapy with curcumin for combating SARS-CoV-2

Photobiomodulation and Antiviral Photodynamic Therapy in COVID-19 Management